Αποτελέσματα Αναζήτησης
15 Ιαν 2010 · A recent trial using a variety of acceptable regimens in patients aged 60 to 80 showed a 2-year survival of 25% to 31%.[101] High-dose chemotherapy with autologous stem cell transplant is feasible in a select population of fit older patients.[102]
25 Μαΐ 2023 · Chemotherapy success rates and cancer survival rates can vary. This article outlines the use of chemotherapy drugs in the treatment of different cancers. We describe how many people with...
Results. Of the 4689 patients treated with chemotherapy over the 5 year period, 133 patients (3%) were ≥ 80 years old. The median age was 83 years. 61% were females and 39% were males. 16% had hematologic tumors and 84% had solid tumors.
7 Αυγ 2019 · Among men aged 85 years and older, prostate and lung cancers are the most common causes of cancer death, together representing 40% of cancer deaths. Among women, lung cancer is the leading cause of cancer death (19%) followed by breast cancer (13%) (Table 1).
26 Αυγ 2020 · A recent retrospect cohort study utilizing data from the National Cancer Database (NCD) sought to determine whether the receipt of adjuvant chemotherapy was associated with survival benefits in patients aged 70 years or older with multiple comorbidities and with node-positive, estrogen-receptor (ER)-positive BC.
23 Ιουν 2022 · Testicular cancer survival has increased from 83% in patients who were diagnosed during the mid-1970s to 95% in the most recent time period, largely because of the success of chemotherapy regimens for advanced disease.
In this study (N = 121), pCR was numerically higher with pertuzumab based regimens, including ddAC-THP (60%), TCHP (63%), THP (55%), as compared with ddAC-TH (46%). THP resulted in significantly less cycle delays due to toxicity compared to the other regimens (p=0.02).
